DoJ filing in Moderna patent case poses immunity questions

Credit: Giovanni Cancemi/ Adobe Stock
The US government claimed Moderna should be immune from patent infringement under Section 1498, raising questions about when the doctrine applies
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: